Biogaia AB
STO:BIOG B
BIOG B's latest stock split occurred on May 18, 2022
The company executed a 5-for-1 stock split, meaning that for every share held, investors received 5 new shares.
Before the split, BIOG B traded at 511 per share. Afterward, the share price was about 98.852.
The adjusted shares began trading on May 18, 2022. This was BIOG B's 2nd stock split, following the previous one in Jun 3, 1998.
CPI
AXI
Biogaia AB
Glance View
BioGaia AB engages in the development, marketing, and sale of probiotic products. The company is headquartered in Stockholm, Stockholm. The firm develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The firm operates worldwide.
You don't have any saved screeners yet